NO TWO PEOPLE ARE THE SAME and genetic differences mean that even if a treatment works for one patient, it may not work for another.
Our collective vision to offer advanced genetic testing at London Health Sciences Centre (LHSC) will provide the unprecedented ability to more accurately diagnose patients, predict the progress of their disease and provide highly targeted and new treatment options. It will have an impact on countless patients locally, nationally and around the globe who have cancer, epilepsy, neuromuscular disorders, developmental disabilities and countless other diseases linked to genetics. Benefitting LHSC patients and families first, the genomics program is leading to personalized treatment options and better care.
Please support TASTINGS and our vision to offer the most advanced care to patients and families in our region.
Attendees Make a Difference
Highlighted below are some examples of our community’s collaborative impact on patient care at LHSC.
Cancer Patient Assistance Program
By participating in the silent auction at TASTINGS 2019, guests directly supported the London Regional Cancer Program's (LRCP) Patient Assistance Program, which relies 100 per cent on donations. For more information, please click here.
Proudly Supported Cancer Research
TASTINGS has supported various activities within the Head and Neck Cancer Research Program, including: the program’s recent participation in a global study that reveals new insights into the cause and structure of one of the most aggressive, and most lethal, cancers; as well as, a world’s first clinical trial comparing surgery versus radiation for a specific thyroid cancer that specifically focuses on a patient’s quality of life.
Purchased New Genetic Testing Equipment for Cancer Treatment
Thanks to the funds raised at TASTINGS, LHSC's London Regional Cancer Program purchased the MiSeq Genome Sequencer which has sparked investment in additional equipment and talent. As a result, more samples are tested simultaneously on-site, eliminating patient wait time from four months to weeks, and lowering costs associated with sending samples out of town.
Supported Renovations Inside London Regional Cancer Program (LRCP)
TASTINGS, alongside many donors within the community, has contributed to transforming LRCP into a patient-focused facility to address patient volume, comfort, and access to care.